A Bernard Collins
Overview
Explore the profile of A Bernard Collins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
857
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hullekes F, Uffing A, Verhoeff R, Seeger H, Moos S, Mansur J, et al.
Am J Transplant
. 2024 Feb;
24(6):1016-1026.
PMID: 38341027
Membranous nephropathy (MN) is a leading cause of kidney failure worldwide and frequently recurs after transplant. Available data originated from small retrospective cohort studies or registry analyses; therefore, uncertainties remain...
2.
Rosales I, Kinoshita K, Maenaka A, How I, Selig M, Laguerre C, et al.
Am J Transplant
. 2023 Aug;
24(1):30-36.
PMID: 37633449
De novo membranous nephropathy (dnMN) is an uncommon immune complex-mediated late complication of human kidney allografts that causes proteinuria. We report here the first case of dnMN in a pig-to-baboon...
3.
Watts A, Keller K, Lerner G, Rosales I, Collins A, Sekulic M, et al.
J Am Soc Nephrol
. 2021 Nov;
33(1):238-252.
PMID: 34732507
Background: Failure of the glomerular filtration barrier, primarily by loss of slit diaphragm architecture, underlies nephrotic syndrome in minimal change disease. The etiology remains unknown. The efficacy of B cell-targeted...
4.
Zonozi R, Laliberte K, Huizenga N, Rosenthal J, Jeyabalan A, Collins A, et al.
Am J Kidney Dis
. 2021 Jun;
78(6):793-803.
PMID: 34174365
Rationale & Objective: B-cell depletion with rituximab has emerged as a first-line therapy for primary membranous nephropathy (MN). However, most patients do not achieve complete remission with rituximab monotherapy. In...
5.
Gallan A, Garg A, Collins A, Beck Jr L, Trivin-Avillach C, Henriksen K, et al.
Kidney Int Rep
. 2020 Dec;
5(12):2365-2370.
PMID: 33305133
No abstract available.
6.
Garcia Y, Collins A, Stone J
Hum Pathol
. 2017 Nov;
72:71-79.
PMID: 29133141
In the past, the diagnosis and typing of amyloidosis often required an invasive biopsy of an internal organ, such as the heart or kidneys. Abdominal fat pad excisional biopsy (FPEB)...
7.
Larsen C, Trivin-Avillach C, Coles P, Collins A, Merchant M, Ma H, et al.
J Am Soc Nephrol
. 2017 Oct;
29(2):644-653.
PMID: 29074737
Primary renal tubulointerstitial disease resulting from proximal tubule antigen-specific antibodies and immune complex formation has not been well characterized in humans. We report a cohort of patients with a distinct,...
8.
Nasr S, Collins A, Alexander M, Schraith D, Hernandez L, Fidler M, et al.
Kidney Int
. 2016 Mar;
89(4):897-908.
PMID: 26994577
Classic anti-glomerular basement membrane (GBM) disease presents with rapidly progressive glomerulonephritis (GN) with or without pulmonary hemorrhage. On biopsy typical disease displays bright polytypic linear GBM staining for IgG by...
9.
Rosales I, Collins A, do Carmo P, Tolkoff-Rubin N, Smith R, Colvin R
J Am Soc Nephrol
. 2015 Sep;
27(2):380-4.
PMID: 26334028
Immune complex tubulointerstitial nephritis due to antibodies to brush border antigens of the proximal tubule has been demonstrated experimentally and rarely in humans. Our patient developed ESRD and early recurrence...
10.
Halushka M, Eng G, Collins A, Judge D, Semigran M, Stone J
J Cardiovasc Transl Res
. 2015 May;
8(4):264-8.
PMID: 25925232
Accurate and rapid classification of cardiac amyloidosis is important for patient management. We have optimized the use of serum free light chain kappa and lambda values to differentiate immunoglobulin light...